BIONOMICS LIMITED - Announcements

0.00%

1.0¢

Currently unlisted.

Bionomics Limited (Bionomics) is an Australia-bases clinical-stage biopharmaceutical... Bionomics Limited (Bionomics) is an Australia-bases clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of novel, ion channel targeting drug candidates designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders. The Company operates in drug development segment in Australia. The Company is advancing its lead drug candidate, BNC210, which is an oral, proprietary, selective negative allosteric modulator of the a7 nicotinic acetylcholine receptor, for the acute treatment of Social Anxiety Disorder (SAD) and chronic treatment of Post-Traumatic Stress Disorder (PTSD). The Company has two drugs in early-stage clinical trials for the treatment of cognitive deficits in Alzheimer’s disease and other central nervous system conditions.More

ASX:PAR

This stock could have something close to a cure for osteoarthritis. Paradigm Biopharmaceuticals (ASX:PAR) is a late-stage drug development company working first and foremost to create a superior treatment for osteoarthritis.

Announcements

Filter Results

All Price Sensitive Only

BNO	Change of Director's Interest Notice		29/11/11	77.15KB	Share
BNO	BNC210 Clinical Data Presented at Neuroscience 2011	PRICE SENSITIVE	15/11/11	31.25KB	Share
BNO	CEO Annual General Meeting Broadcast		11/11/11	32.75KB	Share
BNO	Annual General Meeting Results 2011		09/11/11	21.07KB	Share
BNO	CEO's AGM Presentation 2011		09/11/11	2.36MB	Share
BNO	Chairman's AGM Presentation 2011		09/11/11	174.16KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	28/10/11	38.06KB	Share
BNO	Investor Presentation - ASX Small to Mid Caps		25/10/11	855.24KB	Share
BNO	Notice of Annual General Meeting/Proxy Form		07/10/11	415.51KB	Share
BNO	Bionomics Annual Report 2011		07/10/11	6MB	Share
BNO	Open Briefing - CEO on BNC105 Update and Outlook		05/10/11	210.23KB	Share
BNO	BNC105 Renal Cancer Trial Update	PRICE SENSITIVE	20/09/11	55.16KB	Share
BNO	Latest BNC210 Data Presented at Major Intl Conference		01/09/11	55.16KB	Share
BNO	Full Year Statutory Accounts		18/08/11	775.42KB	Share
BNO	Bionomics' 2010/2011 Preliminary Final Results	PRICE SENSITIVE	18/08/11	96.41KB	Share
BNO	BNO CEO Broadcast - Clinical Trials Reach Key Milestones		12/08/11	33.16KB	Share
BNO	BNO Investor Presentation - August 2011		03/08/11	1.02MB	Share
BNO	BNC105 Clinical Trials Reach Key Milestones	PRICE SENSITIVE	03/08/11	46.55KB	Share
BNO	Trading Halt	PRICE SENSITIVE	01/08/11	40.19KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/11	42.04KB	Share
BNO	Change of Director's Interest Notice		05/07/11	112.64KB	Share
BNO	Lapse of Options		29/06/11	22.02KB	Share
BNO	Phase I BNC105 Clinical Trial Published	PRICE SENSITIVE	23/06/11	36.2KB	Share
BNO	Merck Serono Extends MS Collaboration with Bionomics	PRICE SENSITIVE	09/06/11	34.16KB	Share
BNO	Change of Director's Interest Notice		03/06/11	113.15KB	Share
BNO	Appendix 3B		03/06/11	171.87KB	Share
BNO	BNC105 Renal Cancer Trial To Be Presented AT ASCO	PRICE SENSITIVE	03/06/11	26.51KB	Share
BNO	Appendix 3B		25/05/11	171.5KB	Share
BNO	Open Briefing - Outlook and Strategic Focus	PRICE SENSITIVE	25/05/11	203.47KB	Share
BNO	Becoming a substantial holder		20/05/11	86.82KB	Share
BNO	Appendix 3B		19/05/11	171.1KB	Share
BNO	Change of Director's Interest Notice		18/05/11	111.88KB	Share
BNO	Cleansing Notice Under Section 708A of the Corporations Act		18/05/11	25.4KB	Share
BNO	Appointment of Chief Financial Officer and Company Secretary		16/05/11	24.82KB	Share
BNO	Change in substantial holding		13/05/11	66.6KB	Share
BNO	Successful Register Repositioning Complete	PRICE SENSITIVE	13/05/11	33.45KB	Share
BNO	Trading Halt	PRICE SENSITIVE	12/05/11	33.48KB	Share
BNO	Start-up Australia Ventures Sells 60 Millions BNO Shares	PRICE SENSITIVE	12/05/11	42.94KB	Share
BNO	BNC210 - Further Validation	PRICE SENSITIVE	10/05/11	42.03KB	Share
BNO	Bionomics NOW May 2011 Newsletter		06/05/11	1.13MB	Share
BNO	BNO Sells Thebarton Premises to Boost Cash Reserves	PRICE SENSITIVE	04/05/11	22.47KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/11	16.53KB	Share
BNO	Bionomics April Investor Presentation		14/04/11	845.41KB	Share
BNO	Response to ASX Price Query	PRICE SENSITIVE	13/04/11	99.24KB	Share
BNO	Appendix 3B		13/04/11	160.86KB	Share
BNO	Bionomics Presents at Needham Healthcare Conference		06/04/11	23.76KB	Share
BNO	Broadcast - CEO on Anit-Anxiety Drug Clinical Trials Results		05/04/11	32.73KB	Share
BNO	BNC105 Data Presented at AACR Conference		01/04/11	37.39KB	Share
BNO	Invitation to Tender for Shares	PRICE SENSITIVE	30/03/11	24.33KB	Share
BNO	Anti-Anxiety Drug Clinical Trials Successful Results	PRICE SENSITIVE	30/03/11	160.67KB	Share
BNO	Trading Halt	PRICE SENSITIVE	28/03/11	43.09KB	Share
BNO	Change in substantial holding		09/03/11	116.94KB	Share
BNO	Appendix 3B		23/02/11	160.26KB	Share
BNO	Half Yearly Report and Accounts	PRICE SENSITIVE	11/02/11	752.24KB	Share
BNO	Bionomics NOW February 2011 Newsletter		10/02/11	1.11MB	Share
BNO	BNC105 Data Presented at Lorne Cancer Conference		10/02/11	37.4KB	Share
BNO	Patent Applications Filed on Compounds to Treat Memory Loss	PRICE SENSITIVE	04/02/11	37.63KB	Share
BNO	Open Briefing - CEO on BNC Clinical Trials and Cash Position		01/02/11	193.72KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/11	16.66KB	Share
BNO	Appendix 3B		19/01/11	160.27KB	Share
BNO	Bionomics Biotech Showcase Presentation		10/01/11	861.88KB	Share
BNO	CEO Update and US Investor Presentation		10/01/11	24.86KB	Share
BNO	Bionomics NOW December 2010 Newsletter		17/12/10	752.88KB	Share
BNO	Directors' and Executive Management Share Trading Policy		07/12/10	54.86KB	Share
BNO	Bionomics Appoints Corporate Adviser		26/11/10	25.11KB	Share
BNO	Open Briefing - CEO on Company Update and BNC210 Results	PRICE SENSITIVE	25/11/10	191.13KB	Share
BNO	Latest BNC210 Data presented at US Neuroscience Conference		15/11/10	28.7KB	Share
BNO	Invitation to Tender for the Purchase of Bionomics Shares		11/11/10	49.92KB	Share
BNO	Invitation to tender for the purchase of 27.76% of shares	PRICE SENSITIVE	10/11/10	90.78KB	Share
BNO	Appendix 3B		10/11/10	160.28KB	Share
BNO	Change of Director's Interest Notice		09/11/10	17.54KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	27/10/10	16.18KB	Share
BNO	Bionomics' CEO and Managing Director Extends Contract		18/10/10	50.46KB	Share
BNO	Annual General Meeting 2010 Results		15/10/10	79.45KB	Share
BNO	CEO's Address to Shareholders		15/10/10	451.04KB	Share
BNO	Chairman's Address to Shareholders		15/10/10	118.02KB	Share
BNO	Bionomics Broadcast - CEO on Granted BNC210 European Trials		11/10/10	32.54KB	Share
BNO	BNC210 - European Approval Granted for Two Phase Ib Trials	PRICE SENSITIVE	05/10/10	67.55KB	Share
BNO	Bionomics 2010 Annual Report and Notice of Meeting		14/09/10	8.79MB	Share
BNO	Open Briefing - BNO CEO on BNC210 Clinical Trials	PRICE SENSITIVE	02/09/10	191.58KB	Share
BNO	BNC210 Data Presented at Leading European Forum	PRICE SENSITIVE	30/08/10	61.64KB	Share
BNO	Full Year Statutory Accounts	PRICE SENSITIVE	19/08/10	81.95KB	Share
BNO	Full Year Statutory Accounts		19/08/10	6.74MB	Share
BNO	Appendix 4C - quarterly - corrected		19/07/10	16.99KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	19/07/10	17KB	Share
BNO	Bionomics NOW - July Newsletter		13/07/10	1.23MB	Share
BNO	Lapse of Options		06/07/10	1.01MB	Share
BNO	Change of Director's Interest Notice		22/06/10	17.1KB	Share
BNO	BNC210 Phase I Trial Successful	PRICE SENSITIVE	21/06/10	69.67KB	Share
BNO	Bionomics Presents BNC105 Clinical Data at ASCO	PRICE SENSITIVE	07/06/10	36.59KB	Share
BNO	Open Briefing - CEO on Merck Serono Extension	PRICE SENSITIVE	25/05/10	223.72KB	Share
BNO	Merck Serono Agreement Extended	PRICE SENSITIVE	24/05/10	35.05KB	Share
BNO	Bionomics Limited Broadcast		13/05/10	31.78KB	Share
BNO	Appendix 3B		10/05/10	160.3KB	Share
BNO	Second BNC210 Phase I Clinical Trial Commences	PRICE SENSITIVE	06/05/10	37.71KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	21/04/10	17KB	Share
BNO	New BNC105 Data Presented at International Cancer Conference	PRICE SENSITIVE	16/04/10	38.1KB	Share
BNO	Appendix 3B		14/04/10	160.22KB	Share
BNO	Open Briefing - CEO on Clinical Trials Update	PRICE SENSITIVE	31/03/10	191.87KB	Share
BNO	Appendix 3B		29/03/10	160.32KB	Share

BNOChange of Director's Interest Notice
29/11/11		77.15KB	Share
BNOBNC210 Clinical Data Presented at Neuroscience 2011
15/11/11	PRICE SENSITIVE	31.25KB	Share
BNOCEO Annual General Meeting Broadcast
11/11/11		32.75KB	Share
BNOAnnual General Meeting Results 2011
09/11/11		21.07KB	Share
BNOCEO's AGM Presentation 2011
09/11/11		2.36MB	Share
BNOChairman's AGM Presentation 2011
09/11/11		174.16KB	Share
BNOAppendix 4C - quarterly
28/10/11	PRICE SENSITIVE	38.06KB	Share
BNOInvestor Presentation - ASX Small to Mid Caps
25/10/11		855.24KB	Share
BNONotice of Annual General Meeting/Proxy Form
07/10/11		415.51KB	Share
BNOBionomics Annual Report 2011
07/10/11		6MB	Share
BNOOpen Briefing - CEO on BNC105 Update and Outlook
05/10/11		210.23KB	Share
BNOBNC105 Renal Cancer Trial Update
20/09/11	PRICE SENSITIVE	55.16KB	Share
BNOLatest BNC210 Data Presented at Major Intl Conference
01/09/11		55.16KB	Share
BNOFull Year Statutory Accounts
18/08/11		775.42KB	Share
BNOBionomics' 2010/2011 Preliminary Final Results
18/08/11	PRICE SENSITIVE	96.41KB	Share
BNOBNO CEO Broadcast - Clinical Trials Reach Key Milestones
12/08/11		33.16KB	Share
BNOBNO Investor Presentation - August 2011
03/08/11		1.02MB	Share
BNOBNC105 Clinical Trials Reach Key Milestones
03/08/11	PRICE SENSITIVE	46.55KB	Share
BNOTrading Halt
01/08/11	PRICE SENSITIVE	40.19KB	Share
BNOAppendix 4C - quarterly
29/07/11	PRICE SENSITIVE	42.04KB	Share
BNOChange of Director's Interest Notice
05/07/11		112.64KB	Share
BNOLapse of Options
29/06/11		22.02KB	Share
BNOPhase I BNC105 Clinical Trial Published
23/06/11	PRICE SENSITIVE	36.2KB	Share
BNOMerck Serono Extends MS Collaboration with Bionomics
09/06/11	PRICE SENSITIVE	34.16KB	Share
BNOChange of Director's Interest Notice
03/06/11		113.15KB	Share
BNOAppendix 3B
03/06/11		171.87KB	Share
BNOBNC105 Renal Cancer Trial To Be Presented AT ASCO
03/06/11	PRICE SENSITIVE	26.51KB	Share
BNOAppendix 3B
25/05/11		171.5KB	Share
BNOOpen Briefing - Outlook and Strategic Focus
25/05/11	PRICE SENSITIVE	203.47KB	Share
BNOBecoming a substantial holder
20/05/11		86.82KB	Share
BNOAppendix 3B
19/05/11		171.1KB	Share
BNOChange of Director's Interest Notice
18/05/11		111.88KB	Share
BNOCleansing Notice Under Section 708A of the Corporations Act
18/05/11		25.4KB	Share
BNOAppointment of Chief Financial Officer and Company Secretary
16/05/11		24.82KB	Share
BNOChange in substantial holding
13/05/11		66.6KB	Share
BNOSuccessful Register Repositioning Complete
13/05/11	PRICE SENSITIVE	33.45KB	Share
BNOTrading Halt
12/05/11	PRICE SENSITIVE	33.48KB	Share
BNOStart-up Australia Ventures Sells 60 Millions BNO Shares
12/05/11	PRICE SENSITIVE	42.94KB	Share
BNOBNC210 - Further Validation
10/05/11	PRICE SENSITIVE	42.03KB	Share
BNOBionomics NOW May 2011 Newsletter
06/05/11		1.13MB	Share
BNOBNO Sells Thebarton Premises to Boost Cash Reserves
04/05/11	PRICE SENSITIVE	22.47KB	Share
BNOAppendix 4C - quarterly
29/04/11	PRICE SENSITIVE	16.53KB	Share
BNOBionomics April Investor Presentation
14/04/11		845.41KB	Share
BNOResponse to ASX Price Query
13/04/11	PRICE SENSITIVE	99.24KB	Share
BNOAppendix 3B
13/04/11		160.86KB	Share
BNOBionomics Presents at Needham Healthcare Conference
06/04/11		23.76KB	Share
BNOBroadcast - CEO on Anit-Anxiety Drug Clinical Trials Results
05/04/11		32.73KB	Share
BNOBNC105 Data Presented at AACR Conference
01/04/11		37.39KB	Share
BNOInvitation to Tender for Shares
30/03/11	PRICE SENSITIVE	24.33KB	Share
BNOAnti-Anxiety Drug Clinical Trials Successful Results
30/03/11	PRICE SENSITIVE	160.67KB	Share
BNOTrading Halt
28/03/11	PRICE SENSITIVE	43.09KB	Share
BNOChange in substantial holding
09/03/11		116.94KB	Share
BNOAppendix 3B
23/02/11		160.26KB	Share
BNOHalf Yearly Report and Accounts
11/02/11	PRICE SENSITIVE	752.24KB	Share
BNOBionomics NOW February 2011 Newsletter
10/02/11		1.11MB	Share
BNOBNC105 Data Presented at Lorne Cancer Conference
10/02/11		37.4KB	Share
BNOPatent Applications Filed on Compounds to Treat Memory Loss
04/02/11	PRICE SENSITIVE	37.63KB	Share
BNOOpen Briefing - CEO on BNC Clinical Trials and Cash Position
01/02/11		193.72KB	Share
BNOAppendix 4C - quarterly
31/01/11	PRICE SENSITIVE	16.66KB	Share
BNOAppendix 3B
19/01/11		160.27KB	Share
BNOBionomics Biotech Showcase Presentation
10/01/11		861.88KB	Share
BNOCEO Update and US Investor Presentation
10/01/11		24.86KB	Share
BNOBionomics NOW December 2010 Newsletter
17/12/10		752.88KB	Share
BNODirectors' and Executive Management Share Trading Policy
07/12/10		54.86KB	Share
BNOBionomics Appoints Corporate Adviser
26/11/10		25.11KB	Share
BNOOpen Briefing - CEO on Company Update and BNC210 Results
25/11/10	PRICE SENSITIVE	191.13KB	Share
BNOLatest BNC210 Data presented at US Neuroscience Conference
15/11/10		28.7KB	Share
BNOInvitation to Tender for the Purchase of Bionomics Shares
11/11/10		49.92KB	Share
BNOInvitation to tender for the purchase of 27.76% of shares
10/11/10	PRICE SENSITIVE	90.78KB	Share
BNOAppendix 3B
10/11/10		160.28KB	Share
BNOChange of Director's Interest Notice
09/11/10		17.54KB	Share
BNOAppendix 4C - quarterly
27/10/10	PRICE SENSITIVE	16.18KB	Share
BNOBionomics' CEO and Managing Director Extends Contract
18/10/10		50.46KB	Share
BNOAnnual General Meeting 2010 Results
15/10/10		79.45KB	Share
BNOCEO's Address to Shareholders
15/10/10		451.04KB	Share
BNOChairman's Address to Shareholders
15/10/10		118.02KB	Share
BNOBionomics Broadcast - CEO on Granted BNC210 European Trials
11/10/10		32.54KB	Share
BNOBNC210 - European Approval Granted for Two Phase Ib Trials
05/10/10	PRICE SENSITIVE	67.55KB	Share
BNOBionomics 2010 Annual Report and Notice of Meeting
14/09/10		8.79MB	Share
BNOOpen Briefing - BNO CEO on BNC210 Clinical Trials
02/09/10	PRICE SENSITIVE	191.58KB	Share
BNOBNC210 Data Presented at Leading European Forum
30/08/10	PRICE SENSITIVE	61.64KB	Share
BNOFull Year Statutory Accounts
19/08/10	PRICE SENSITIVE	81.95KB	Share
BNOFull Year Statutory Accounts
19/08/10		6.74MB	Share
BNOAppendix 4C - quarterly - corrected
19/07/10		16.99KB	Share
BNOAppendix 4C - quarterly
19/07/10	PRICE SENSITIVE	17KB	Share
BNOBionomics NOW - July Newsletter
13/07/10		1.23MB	Share
BNOLapse of Options
06/07/10		1.01MB	Share
BNOChange of Director's Interest Notice
22/06/10		17.1KB	Share
BNOBNC210 Phase I Trial Successful
21/06/10	PRICE SENSITIVE	69.67KB	Share
BNOBionomics Presents BNC105 Clinical Data at ASCO
07/06/10	PRICE SENSITIVE	36.59KB	Share
BNOOpen Briefing - CEO on Merck Serono Extension
25/05/10	PRICE SENSITIVE	223.72KB	Share
BNOMerck Serono Agreement Extended
24/05/10	PRICE SENSITIVE	35.05KB	Share
BNOBionomics Limited Broadcast
13/05/10		31.78KB	Share
BNOAppendix 3B
10/05/10		160.3KB	Share
BNOSecond BNC210 Phase I Clinical Trial Commences
06/05/10	PRICE SENSITIVE	37.71KB	Share
BNOAppendix 4C - quarterly
21/04/10	PRICE SENSITIVE	17KB	Share
BNONew BNC105 Data Presented at International Cancer Conference
16/04/10	PRICE SENSITIVE	38.1KB	Share
BNOAppendix 3B
14/04/10		160.22KB	Share
BNOOpen Briefing - CEO on Clinical Trials Update
31/03/10	PRICE SENSITIVE	191.87KB	Share
BNOAppendix 3B
29/03/10		160.32KB	Share

REFRESH

First 5 6 7 8 9

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

BIONOMICS LIMITED - Announcements

Announcements

Top Stories